LDV Capital
  • Home
  • Portfolio
  • Vision Events
  • Insights
  • News
  • Community
  • Blog
  • About
LDV Capital
  • Home /
  • Portfolio/
  • Vision Events/
  • Insights/
  • News/
  • Community/
  • Blog/
  • About/
LDV Capital

LDV Blog

LDV Capital
  • Home /
  • Portfolio/
  • Vision Events/
  • Insights/
  • News/
  • Community/
  • Blog/
  • About/
November 01, 2024

Drug Discoverer Shares Opportunities in Therapeutics & AI

November 01, 2024/ Kat Lopez
Drug Discoverer Shares Opportunities in Therapeutics & AI

Dr. David Rabuka is a serial biotech entrepreneur and investor based in Berkeley California. His expertise is concentrated on translating new technologies into clinical therapies. In 2024, Dr. Rabuka spoke about investment trends & opportunities in ​​life sciences and biotech at our Annual General Meeting. Check out our shortened & lightly edited transcript.

Read More
November 01, 2024/ Kat Lopez/
Biotech & Life Sciences
Investment Trends, Life Sciences, Biotech, Dr. David Rabuka, serial biotech entrepreneur, investor, clinical therapies, Redwood Biosciences, Carolyn Bertozzi, Catalent Pharma Solutions, LDV Capital, visual technology, artificial intelligence, AI, healthcare, Dr. Laura Smoliar, LDV experts, Annual General Meeting, therapeutics, personalized medicine, biotech industry, genetic makeup, medical treatments, supply chain, GLP-1, weight loss drugs, anti-cancer drugs, antibody-drug conjugates, chemotherapy, radioisotope therapies, Zevalin, Bexxar, radioactive materials, small-molecule therapies, biologics, antibodies, barbell drugs, synthetic macromolecules, PROTACs, new therapeutic modalities, mRNA, Large datasets
March 15, 2022

Visual Tech is Critical to the Future of Life Sciences

March 15, 2022/ Kat Lopez
Visual Tech is Critical to the Future of Life Sciences

In the lead-up to our 8th Annual LDV Vision Summit, Evan Nisselson had the privilege of chatting with Amy Kruse, General Partner of Prime Movers Lab. On March 23rd, she will take part in our panel discussion on investing trends in businesses powered by visual technologies.

Read More
March 15, 2022/ Kat Lopez/
Biotech & Life Sciences
Amy Kruse, Prime Movers Lab, life sciences investments, neuroscience, human augmentation, synthetic biology, longevity, regeneration, agriculture, Paradromics, Gilgamesh Pharmaceuticals, Cognixion, Iridia, IVIVA Medical, Attune Neurosciences, Optios, Cubic Global Defense, DARPA, performance-oriented neuroscience programs, Loomis Innovation Council, Singularity University, Cell and Structural Biology, University of Illinois Champaign-Urbana, NSF Graduate Fellowship, venture capital, investing, life sciences, visual tech, sensors, inputs, imaging, healthcare, omics, personalized medicine, AR, VR, digital therapies, mental health therapeutics, behavioral health interventions, neurotechnology, EEG, electroencephalography, eye tracking, AR interface, augmented cognition, accelerated learning, cognitive enhancement, team neurodynamics, brain stimulation, mental health

Stay In The Know

From New Materials to Biotech, Neuroscience and More: Your Monthly Dispatch on All Things Visual Tech & AI

Thank you!

©LDV Capital